Related Experiment Video

Updated: Jul 11, 2026

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

Multidrug resistance in cancer: its mechanism and its modulation

Ernest K J Pauwels1, Paula Erba, Giuliano Mariani

  • 1Leiden University, The Netherlands. ernestpauwels@gmail.com

Drug News & Perspectives
|October 11, 2007
PubMed

Insights

Cancer drug resistance is a major challenge, often caused by ATP-binding cassette (ABC) transporters that reduce drug effectiveness. New strategies like nanomedicine show promise but require further clinical validation.

Area of Science:

  • Pharmacology and Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • Drug resistance is a significant hurdle in cancer therapy, impacting treatment efficacy.
  • ATP-binding cassette (ABC) transporters are key transmembrane proteins involved in drug efflux and xenobiotic elimination.
  • Understanding ABC transporter mechanisms is crucial for developing effective cancer treatments.

Purpose of the Study:

  • To review recent advancements in understanding ATP-binding cassette (ABC) transporters in cancer drug resistance.
  • To highlight the clinical significance and potential modulation strategies for ABC transporters.
  • To explore novel approaches, including nanomedicine, for overcoming multidrug resistance.

Main Methods:

  • Literature review of recent research on ABC transporters and cancer drug resistance.
  • Analysis of mechanisms of action, clinical significance, and modulation of ABC transporters.
  • Evaluation of emerging strategies to circumvent drug efflux mechanisms.

Main Results:

  • ABC transporters mediate cancer drug resistance by reducing drug bioavailability and facilitating xenobiotic elimination.
  • Clinical significance of ABC transporters in treatment failure and acquired resistance is substantial.
  • Novel therapeutic strategies, including transporter inhibition and nanomedicine, are being developed.

Conclusions:

  • Despite progress, the clinical application of knowledge on ABC transporters and multidrug resistance is still in its early stages.
  • Further research and clinical trials are necessary to translate novel approaches into effective patient therapies.
  • Modulating ABC transporter activity remains a critical target for improving cancer treatment outcomes.

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...